BPC-157 offers a broad spectrum of potential benefits, which include: Pain Management Derived from gastric juice, BPC-157 is a peptide that has shown great potential in managing discomfort caused by musculoskeletal injuries, arthritis, and joint pain
Most clinicians advise caution and reduced alcohol consumption during treatment
The key question for many patients is whether semaglutide contains sulfa or if it is safe for people with sulfa allergies
found lower risks of AF in the SGLT2i group compared with the matched DPP4i group or the matched GLP-1RA group (HR=0.82 [95% CI: 0.76 to 0.89] and 0.90 [95% CI: 0.83 to 0.98], respectively), whereas the risk of AF between GLP-1RA and DPP4i was not evaluated
federal research data in which people were asked about their GLP-1 prescriptions.Results showed that among people without diabetes, GLP-1 drug use rose from 0.1% of the population in 2018 to 0.4% in 2022.That doesnt seem like a lot, amounting to an estimated 854,000 Americans without diabetes using GLP-1 drugs to lose weight in 2022, but the drugs are costly, and can run close to $1,000 or more a month, researchers found.As a result, estimated annual spending on GLP-1 drugs among non-diabetics rose from $1.6 billion between 2018 and 2021 to $5.8 billion in 2022, the study showed.On average, the drugs cost $1,540 per prescription, but patients paid an average of just under $35 out-of-pocket for each prescription.The study provides the first characterization of nationwide GLP-1 use and spending among individuals without diabetes to guide ongoing debates about balancing the sustainability of health care spending against improving accessibility and affordability of GLP-1 medications going forward, researchers concluded.More informationHarvard Medical School has more on insurance coverage for GLP-1 drugs.SOURCE: Annals of Internal Medicine, March 31, 2025 .What This Means For YouPeople who are obese should talk to their doctor about whether they qualify for insurance coverage for a GLP-1 drug..Sign up for our weekly HealthDay newsletter
